Magaldrate + Simethicone interactions
Checked as Magaldrate + Simethicone in this data source.
Full monograph for Magaldrate + SimethiconeCheck it against another medicine
Medicines
222 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Erdafitinibvia Magaldrate | Major | Others | Coadministration with agents that can alter serum phosphate levels may affect the initial dosage determination of erdafitinib. The mechanism appears to be… | 1 sources — open the full entry |
| Selpercatinibvia Magaldrate | Major | Absorption | Coadministration with drugs that increase gastric pH may significantly decrease the oral bioavailability of selpercatinib and reduce its concentrations in… | 2 sources — open the full entry |
| Sotorasibvia Magaldrate | Major | Absorption | Coadministration with drugs that increase gastric pH may significantly decrease the oral bioavailability of sotorasib and reduce its concentrations in plasma. | 2 sources — open the full entry |
| Acalabrutinibvia Magaldrate | Moderate | Absorption | INTERVAL: Coadministration with drugs that increase gastric pH may significantly decrease the oral bioavailability of acalabrutinib and reduce its… | 2 sources — open the full entry |
| Alendronic acidvia Magaldrate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to… | 9 sources — open the full entry |
| Alendronic Acid + Vitamin D3via Magaldrate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to… | 9 sources — open the full entry |
| Allopurinolvia Magaldrate | Moderate | Absorption | INTERVAL: Aluminum-containing oral medications may decrease the absorption of allopurinol and reduce its therapeutic effect. | 2 sources — open the full entry |
| Aspirinvia Magaldrate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Aspirin + Dipyridamolevia Magaldrate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Atropine Sulfate (Injection)via Magaldrate | Moderate | Absorption | INTERVAL: Concurrent administration of antacids or adsorbent antidiarrheal agents may decrease the oral bioavailability of atropine. | 1 sources — open the full entry |
| Azithromycin DihydratebaseOphthalmicvia Magaldrate | Moderate | Absorption | INTERVAL: The concomitant administration of aluminum or magnesium-containing antacids may reduce peak serum concentrations (Cmax) of oral azithromycin, but… | 1 sources — open the full entry |
| Baloxavir Marboxilvia Magaldrate | Moderate | Absorption | Coadministration with polyvalent cation-containing products may decrease the plasma concentrations and therapeutic efficacy of baloxavir. The proposed… | 3 sources — open the full entry |
| Benzoic Acid + Salicylic Acidvia Magaldrate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Betamethasone Dipropionate + Salicylic Acidvia Magaldrate | Moderate | Absorption · Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism…2 documented mechanisms | 11 sources — open the full entry |
| Bisacodylvia Magaldrate | Moderate | Absorption | INTERVAL: By increasing gastric pH, antacids may reduce the resistance of the enteric coating of bisacodyl tablets, resulting in earlier release of bisacodyl… | 1 sources — open the full entry |
| Carbonyl Iron + Folic Acidvia Magaldrate | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Carbonyl Iron + Folic Acid + Zinc Sulfatevia Magaldrate | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Carbonyl Iron + Folic Acid + Zinc Sulfate + Vitamin B Complex + Vitamin Cvia Magaldrate | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Cefdinirvia Magaldrate | Moderate | Absorption | INTERVAL: Aluminum- or magnesium-containing antacids may interfere with the rate and extent of absorption of cefdinir. The mechanism has not been described but… | 1 sources — open the full entry |
| Cefditorenvia Magaldrate | Moderate | Absorption | Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral absorption and plasma concentrations of cefditoren pivoxil. | 2 sources — open the full entry |
| Cefpodoxime Proxetilvia Magaldrate | Moderate | Absorption | INTERVAL: Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral bioavailability of cefpodoxime proxetil and cefuroxime… | 4 sources — open the full entry |
| Cefpodoxime Proxetil + Clavulanic Acidvia Magaldrate | Moderate | Absorption | INTERVAL: Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral bioavailability of cefpodoxime proxetil and cefuroxime… | 4 sources — open the full entry |
| Cefuroxime Axetilvia Magaldrate | Moderate | Absorption | INTERVAL: Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral bioavailability of cefpodoxime proxetil and cefuroxime… | 4 sources — open the full entry |
| Cefuroxime Axetil + Clavulanic Acidvia Magaldrate | Moderate | Absorption | INTERVAL: Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral bioavailability of cefpodoxime proxetil and cefuroxime… | 4 sources — open the full entry |
| Ceritinibvia Magaldrate | Moderate | Absorption | Drugs that alter the pH of the upper gastrointestinal tract may affect the solubility of ceritinib and reduce its bioavailability. The interaction has not been… | 2 sources — open the full entry |
| Cetalkonium Chloride + Choline Salicylatevia Magaldrate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Chloroquine Phosphatevia Magaldrate | Moderate | Absorption | INTERVAL: Concomitant administration of antacids or kaolin may reduce the oral bioavailability of chloroquine. The proposed mechanism is adsorption of… | 9 sources — open the full entry |
| CiprofloxacinbaseOphthalmicvia Magaldrate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Ciprofloxacin + Dexamethasonevia Magaldrate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics…2 documented mechanisms | 35 sources — open the full entry |
| Ciprofloxacin + Hydrocortisone Acetatevia Magaldrate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Clobetasol Propionate + Ofloxacin + Ornidazole + Terbinafinevia Magaldrate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Clobetasol Propionate + Salicylic Acidvia Magaldrate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Clopidogrel + Aspirinvia Magaldrate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Coal Tar + Precipitated Sulphur + Salicylic Acidvia Magaldrate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Dabigatran Etexilate Mesylatevia Magaldrate | Moderate | Absorption | Coadministration with an antacid may reduce the bioavailability of dabigatran following oral administration of dabigatran etexilate. | 1 sources — open the full entry |
| Dasatinibvia Magaldrate | Moderate | Absorption | INTERVAL: Nonclinical data indicate that the solubility of dasatinib is pH-dependent. Therefore, coadministration with antacids or agents with… | 4 sources — open the full entry |
| Deferasiroxvia Magaldrate | Moderate | Absorption | Although deferasirox has a lower affinity for aluminum than for iron, it can theoretically bind aluminum in the gastrointestinal tract. | 3 sources — open the full entry |
| Deferipronevia Magaldrate | Moderate | Absorption | INTERVAL: Deferiprone has the potential to bind polyvalent cations such as aluminum, iron and zinc, which may reduce its effectiveness. However, concurrent use… | 1 sources — open the full entry |
| Delafloxacinvia Magaldrate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
| Dexamethasone + Levofloxacinvia Magaldrate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics…2 documented mechanisms | 35 sources — open the full entry |
| Diclofenac Sodium + Misoprostolvia Magaldrate | Moderate | Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid… | 2 sources — open the full entry |
| Dithranol + Boric Acid + Salicylic Acidvia Magaldrate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Doxycycline Hydrochloridevia Magaldrate | Moderate | Absorption | INTERVAL: Administration of a tetracycline with aluminum, calcium, or magnesium salts significantly decreases tetracycline serum concentrations. The proposed… | 15 sources — open the full entry |
| Eltrombopag Olaminevia Magaldrate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, iron, magnesium, zinc and other polyvalent cations such as antacids or mineral supplements can significantly… | 4 sources — open the full entry |
| Erlotinibvia Magaldrate | Moderate | Absorption | INTERVAL: Concurrent administration of antacids or other agents with acid-neutralizing effects may decrease the oral bioavailability of erlotinib and reduce… | 6 sources — open the full entry |
| Ethinyl Estradiol + Levonorgestrel + Ferrous Fumaratevia Magaldrate | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Ferric Maltolvia Magaldrate | Moderate | Absorption | The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing effects. The… | 12 sources — open the full entry |
| Ferrous Fumarate + Folic acidvia Magaldrate | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Fexofenadine Hydrochloridevia Magaldrate | Moderate | Absorption | INTERVAL: The concomitant administration of aluminum or magnesium-containing antacids with fexofenadine reduces its peak serum concentrations (Cmax) by 43% and… | 3 sources — open the full entry |
| Gatifloxacinvia Magaldrate | Moderate | Absorption | INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics… | 32 sources — open the full entry |
This source documents no food, condition or duplication entries for Magaldrate + Simethicone.